LS Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-258
| Closed | -$22K | – | 1648 |
|
|
2020
Q1 | $22K | Sell |
258
-832
| -76% | -$70.9K | ﹤0.01% | 1331 |
|
|
2019
Q4 | $92K | Hold |
1,090
| – | – | 0.01% | 1134 |
|
|
2019
Q3 | $73K | Hold |
1,090
| – | – | ﹤0.01% | 1174 |
|
|
2019
Q2 | $93K | Hold |
1,090
| – | – | 0.01% | 1100 |
|
|
2019
Q1 | $97K | Hold |
1,090
| – | – | 0.01% | 1099 |
|
|
2018
Q4 | $93K | Sell |
1,090
-361
| -25% | -$30.8K | 0.01% | 1086 |
|
|
2018
Q3 | $141K | Hold |
1,451
| – | – | 0.01% | 1002 |
|
|
2018
Q2 | $137K | Hold |
1,451
| – | – | 0.01% | 1032 |
|
|
2018
Q1 | $118K | Hold |
1,451
| – | – | 0.01% | 1065 |
|
|
2017
Q4 | $129K | Hold |
1,451
| – | – | 0.01% | 1072 |
|
|
2017
Q3 | $135K | Hold |
1,451
| – | – | 0.01% | 1068 |
|
|
2017
Q2 | $132K | Hold |
1,451
| – | – | 0.01% | 1046 |
|
|
2017
Q1 | $127K | Hold |
1,451
| – | – | 0.01% | 1039 |
|
|
2016
Q4 | $120K | Hold |
1,451
| – | – | 0.01% | 983 |
|
|
2016
Q3 | $134K | Sell |
1,451
-495
| -25% | -$45.7K | 0.01% | 915 |
|
|
2016
Q2 | $151K | Buy |
1,946
+231
| +13% | +$17.9K | 0.01% | 868 |
|
|
2016
Q1 | $141K | Buy |
1,715
+72
| +4% | +$5.92K | 0.01% | 744 |
|
|
2015
Q4 | $172K | Buy |
1,643
+179
| +12% | +$18.7K | 0.01% | 673 |
|
|
2015
Q3 | $154K | Hold |
1,464
| – | – | 0.01% | 691 |
|
|
2015
Q2 | $200K | Sell |
1,464
-497
| -25% | -$67.9K | 0.01% | 628 |
|
|
2015
Q1 | $244K | Sell |
1,961
-329
| -14% | -$40.9K | 0.02% | 538 |
|
|
2014
Q4 | $207K | Hold |
2,290
| – | – | 0.02% | 575 |
|
|
2014
Q3 | $165K | Hold |
2,290
| – | – | 0.01% | 596 |
|
|
2014
Q2 | $142K | Sell |
2,290
-90
| -4% | -$5.58K | 0.01% | 621 |
|
|
2014
Q1 | $162K | Hold |
2,380
| – | – | 0.01% | 601 |
|
|
2013
Q4 | $167K | Buy |
+2,380
| New | +$167K | 0.02% | 586 |
|